고위험도 전립선암 환자의 치료 편집하기 (부분)

== 참고문헌 ==
1. Bill-Axelson A, Holmberg L, Garmo H, et al. Radical Prostatectomy or Watchful Waiting in Early Prostate Cancer. N Engl J Med 2014:370(10):932-42. 

2. Tewari A, Divine G, Chang P, et al. Long-Term Survival in Men With High Grade Prostate Cancer: A Comparison Between Conservative Treatment, Radiation Therapy and Radical Prostatectomy-A Propensity Scoring Approach. J Urol 2007:177(3):911-5.. 

3. Wilt TJ, Brawer MK, Jones KM, et al. Radical prostatectomy versus observation for localized prostate cancer. | N Engl J Med 2012:367(3):203-13. 

4. Lei JH, Liu LR, Wei Q, et al. Systematic review and meta-analysis of the survival outcomes of first-line treatment options in high-risk prostate cancer. Sci Rep 2015;5:7713. 

5. Johnston TJ, Shaw GL, Lamb AD, et al. Mortality Among Men with Advanced Prostate Cancer Excluded from the Protect Trial. Eur Urol 2017;71(3):381-8. 

6. Heidenreich A, Pfister D, Porres D. Cytoreductive radical prostatectomy in patients with prostate cancer and low volume skeletal metastases: Results of a feasibility and case-control study. J Urol 2015:193(3):832-8. 

7. Ghadjar P, Briganti A, De Visschere PJL, et al. The oncologic role of local treatment in primary metastatic prostate cancer. World J Urol 2015:33(6):755-61. 

8. Di Benedetto A, Soares R, Dovey Z, et al. Laparoscopic radical prostatectomy for high-risk prostate cancer. BJU Int 2015;115(5):780-6. 

9. Everaerts W, Van Rij S, Reeves F, et al. Radical treatment of localised prostate cancer in the elderly. BJU Int 2015;116(6):847-52. 

10. Gözen AS, Akin Y, Ates M, et al. Impact of laparoscopic radical prostatectomy on clinical T3 prostate cancer: Experience of a single centre with long-term follow-up. BJU Int 2015;116(1):102-8. 

11. Bratt o, Folkvaljon Y, Eriksson MH, et al. Undertreatment of men in their seventies with high-risk nonmetastatic prostate cancer. Eur Urol 2015;68(1):53-8. 

12. Wiegel T, Bartkowiak D, Bottke D, et al. Prostate-specific antigen persistence after radical prostatectomy as a predictive factor of clinical relapse-free survival and overall survival: 10-year data of the ARO 96-02 trial. Int J Radiat Oncol Biol Phys 2015:91(2):288-94. 

13. Abdollah F, Klett DE, Sood A, et al, Predicting pathological outcomes in patients undergoing robot-assisted radical prostatectomy for high-risk prostate cancer: A preoperative nomogram. BJŲ Int 2015;116(5):703-12. 

14. Jo JK, Kook HR, Byun S-S, et al. Stratification of Contemporary Patients Undergoing Radical Prostatectomy for High-risk Prostate cancer. Ann Surg Oncol 2015;22(6):2088-93. 

15. Dell'Oglio P, Karnes RJ, Joniau S, et al. Very long-term survival patterns of young patients treated with radical prostatectomy for high-risk prostate cancer. Urol Oncol 2016;34(5):234.e13-9. 

16. Briganti A, Karnes RJ, Gandaglia G, et al. Natural history of surgically treated high-risk prostate cancer. Urol Oncol 2015;33(4):163.e7-13. 

17. Koie T, Mitsuzuka K, Yoneyama T, et al. Prostate-specific antigen density predicts extracapsular extension and increased risk of biochemical recurrence in patients with high-risk prostate cancer who underwent radical prostatectomy. Int J Clin Oncol 2015;20(1):176-81. 

18. Lanchon C, Shariat SF, Roupret M. The role for surgery in high-risk prostate cancer. Wien Med Wochenschr 2015;165(19-20):395-400. 

19. Djaladat H, Amini E, Xu W, Cai J, Daneshmand S, Lieskovsky G. Oncological Outcomes After Radical Prostatectomy for High-Risk Prostate cancer Based on New Gleason Grouping System: A Validation Study From University of Southern California With 3,755 Cases. Prostate 2017:77(7):743-8.